2μg (R: reducing condition, N:non-reducing condition).
Product Details
Product Details
Product Specification
| Species | Human |
| Synonyms | AHUS2, MCP, MIC10, TLX, TRA2.10 |
| Accession | P15529-3 |
| Amino Acid Sequence | Cys35-Asp328 with His Tag at the C-Terminus |
| Expression System | HEK293 |
| Molecular Weight | 55-70kDa (Reducing) |
| Purity | >95% by SDS-PAGE & HPLC |
| Conjugation | Unconjugated |
| Tag | His Tag |
| Physical Appearance | Lyophilized powder |
| Storage Buffer | PBS, pH7.4, 5% trehalose |
| Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
| Stability & Storage | · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. |
| Reference | 1. AGGARWAL R R, VUKY J, VANDERWEELE D, et al. Phase I, first-in-human study of FOR46 (FG-3246), an immune-modulating antibody-drug conjugate targeting CD46, in patients with metastatic castration-resistant prostate cancer[J]. Journal of Clinical Oncology, 2025, 43(15): 1824-1834. |
Background
CD46, also known as complement regulatory protein or membrane cofactor protein (MCP), is a type I transmembrane glycoprotein widely expressed on human cell surfaces. Its structure comprises four complement control protein repeats (CCPs), a serine/threonine-rich region, a transmembrane domain, and a cytoplasmic tail, with multiple isoforms generated through alternative splicing. The core function of CD46 lies in its role as a key regulator of the complement system, where it serves as a cofactor for the proteolytic cleavage of C3b/C4b by factor I, thereby protecting host cells from complement-mediated cytolysis. Additionally, CD46 acts as a cellular receptor for various pathogens, including measles virus and adenovirus, and participates in modulating T cell metabolism and immune responses. In recent years, CD46 has emerged as a promising therapeutic target in oncology due to its overexpression in multiple solid tumors—such as prostate, bladder, and multiple myeloma—spurring the clinical development of antibody-drug conjugates (ADCs), targeted alpha-particle radiotherapy, and theranostic strategies, all demonstrating favorable therapeutic potential.
Picture
Picture
SDS-PAGE
SEC-HPLC
The purity of CD46 His Tag Protein, Human is more than 95% determined by SEC-HPLC.
ELISA
Immobilized CD46 His Tag Protein, Human (Cat. No. UA016145) at 1.0 μg/mL (100 μL/well) can bind FG-3246(FOR46) with EC50 of 0.43-0.71 ng/mL.
